Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belatacept in Simultaneous Pancreas and Kidney Transplantation (CTOT-15)
NCT01790594Phase 2Terminated
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Feb 2013
- Primary completion
- Aug 2016
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of belatacept in graft rejection, sponsored by National Institute of Allergy and Infectious Diseases. Started Feb 2013; status: terminated.
02
Drugs
belatacept
03
Conditions
graft rejection
Beyond the preview
Go deeper on NCT01790594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01790594.